News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Norway's Pronova BioPharma Sets Up to $1.57 Billion IPO


9/26/2007 7:03:38 AM

OSLO (Reuters) - Norwegian bio-pharmaceutical firm Pronova Biopharma (PRON.OL: Quote, Profile, Research) is offering 105.9 million shares in connection with its planned listing on the Oslo bourse next month, valuing the firm at $1.25 billion to $1.57 billion.

Read at Reuters


comments powered by Disqus
Reuters
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES